Literature DB >> 22395023

Commentary: can mortality rates among adult antiretroviral therapy patients in Europe reach levels similar to those experienced in the general population?

Andrew F Auld, Tedd V Ellerbrock.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22395023      PMCID： PMC7430036          DOI： 10.1093/ije/dys023

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN： 0300-5771            Impact factor:   7.196


× No keyword cloud information.
  12 in total

1.  Estimates of global and regional smoking prevalence in 1995, by age and sex.

Authors:  Prabhat Jha; M Kent Ranson; Son N Nguyen; Derek Yach
Journal:  Am J Public Health       Date:  2002-06       Impact factor: 9.308

2.  Mortality in patients with successful initial response to highly active antiretroviral therapy is still higher than in non-HIV-infected individuals.

Authors:  Ard van Sighem; Sven Danner; Azra C Ghani; Luuk Gras; Roy M Anderson; Frank de Wolf
Journal:  J Acquir Immune Defic Syndr       Date:  2005-10-01       Impact factor: 3.731

Review 3.  Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy.

Authors:  Geetanjali Chander; Seth Himelhoch; Richard D Moore
Journal:  Drugs       Date:  2006       Impact factor: 9.546

4.  All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration.

Authors:  Charlotte Lewden; Vincent Bouteloup; Stéphane De Wit; Caroline Sabin; Amanda Mocroft; Jan Christian Wasmuth; Ard van Sighem; Ole Kirk; Niels Obel; George Panos; Jade Ghosn; François Dabis; Murielle Mary-Krause; Catherine Leport; Santiago Perez-Hoyos; Paz Sobrino-Vegas; Christoph Stephan; Antonella Castagna; Andrea Antinori; Antonella d'Arminio Monforte; Carlo Torti; Cristina Mussini; Virginia Isern; Alexandra Calmy; Ramón Teira; Matthias Egger; Jesper Grarup; Geneviève Chêne
Journal:  Int J Epidemiol       Date:  2011-11-28       Impact factor: 7.196

5.  Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study.

Authors:  Rebecca K Lodwick; Caroline A Sabin; Kholoud Porter; Bruno Ledergerber; Ard van Sighem; Alessandro Cozzi-Lepri; Pavel Khaykin; Amanda Mocroft; Lisa Jacobson; Stephane De Wit; Niels Obel; Antonella Castagna; Jan-Christian Wasmuth; John Gill; Marina B Klein; Stephen Gange; Melchor Riera; Cristina Mussini; Félix Gutiérrez; Giota Touloumi; Patrizia Carrieri; Jodie L Guest; Norbert H Brockmeyer; Andrew N Phillips
Journal:  Lancet       Date:  2010-07-15       Impact factor: 79.321

6.  Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries.

Authors:  Marcel Zwahlen; Ross Harris; Margaret May; Robert Hogg; Dominique Costagliola; Frank de Wolf; John Gill; Gerd Fätkenheuer; Charlotte Lewden; Mike Saag; Sholmo Staszewski; Antonella d'Arminio Monforte; Jordi Casabona; Fiona Lampe; Amy Justice; Viktor von Wyl; Matthias Egger
Journal:  Int J Epidemiol       Date:  2009-10-09       Impact factor: 7.196

7.  Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study.

Authors:  Nina Friis-Møller; Rainer Weber; Peter Reiss; Rodolphe Thiébaut; Ole Kirk; Antonella d'Arminio Monforte; Christian Pradier; Linda Morfeldt; Silvia Mateu; Matthew Law; Wafaa El-Sadr; Stephan De Wit; Caroline A Sabin; Andrew N Phillips; Jens D Lundgren
Journal:  AIDS       Date:  2003-05-23       Impact factor: 4.177

8.  HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population.

Authors:  Charlotte Lewden; Genevieve Chene; Philippe Morlat; Francois Raffi; Michel Dupon; Pierre Dellamonica; Jean-Luc Pellegrin; Christine Katlama; Francois Dabis; Catherine Leport
Journal:  J Acquir Immune Defic Syndr       Date:  2007-09-01       Impact factor: 3.731

9.  Changes in causes of death among adults infected by HIV between 2000 and 2005: The "Mortalité 2000 and 2005" surveys (ANRS EN19 and Mortavic).

Authors:  Charlotte Lewden; Thierry May; Eric Rosenthal; Christine Burty; Fabrice Bonnet; Dominique Costagliola; Eric Jougla; Caroline Semaille; Philippe Morlat; Dominique Salmon; Patrice Cacoub; Geneviève Chêne
Journal:  J Acquir Immune Defic Syndr       Date:  2008-08-15       Impact factor: 3.731

10.  Factors associated with mortality in human immunodeficiency virus type 1-infected adults initiating protease inhibitor-containing therapy: role of education level and of early transaminase level elevation (APROCO-ANRS EP11 study). The Antiprotéases Cohorte Agence Nationale de Recherches sur le SIDA EP 11 study.

Authors:  Charlotte Lewden; François Raffi; Lise Cuzin; Valérie Cailleton; Jean-Louis Vildé; Geneviève Chêne; Clotilde Allavena; Roger Salamon; Catherine Leport
Journal:  J Infect Dis       Date:  2002-07-29       Impact factor: 5.226
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.